Skip to content

Author: Ben Shaberman

FFB Convenes Experts to Discuss Therapeutic Opportunities for Stargardt Disease

Source: Foundation Fighting Blindness Blog – Eye on the Cure – FFB Convenes Experts to Discuss Therapeutic Opportunities for Stargardt Disease Meeting presenters (left to right): Philip Rosenfeld, MD, PhD; Ilyas Washington, PhD; Peter Charbel Issa, MD, PhD; Elias Traboulsi, MD, MEd; Ulrich Schraermeyer, PhD; Carel Hoyng, PhD; Paul…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

AGTC Leverages Funding from the Foundation to Move Promising Treatments into Clinical Trials

Source: Foundation Fighting Blindness Blog – Eye on the Cure – AGTC Leverages Funding from the Foundation to Move Promising Treatments into Clinical Trials Company Builds on FFB’s Initial Investment to Garner $265 Million in Therapy Development Funding In the early 1990s, scientists began discovering the genetic defects causing…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

FFB-CRI Leads Effort to Identify Outcome Measures for Therapies in Clinical Trials

Source: Foundation Fighting Blindness Blog – Eye on the Cure – FFB-CRI Leads Effort to Identify Outcome Measures for Therapies in Clinical Trials Side view of a retina as captured by SD-OCT. The EZ Width is the yellow line extending between the arrows. The patient has advanced RP with…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest